130 related articles for article (PubMed ID: 34596182)
1. Synthesis and evaluation of peptidic thrombin inhibitors bearing acid-stable sulfotyrosine analogues.
Dowman LJ; Agten SM; Ripoll-Rozada J; Calisto BM; Pereira PJB; Payne RJ
Chem Commun (Camb); 2021 Oct; 57(83):10923-10926. PubMed ID: 34596182
[TBL] [Abstract][Full Text] [Related]
2. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
Stone MJ; Payne RJ
Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
Obst U; Banner DW; Weber L; Diederich F
Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
[TBL] [Abstract][Full Text] [Related]
6. Sulfotyrosine-Mediated Recognition of Human Thrombin by a Tsetse Fly Anticoagulant Mimics Physiological Substrates.
Calisto BM; Ripoll-Rozada J; Dowman LJ; Franck C; Agten SM; Parker BL; Veloso RC; Vale N; Gomes P; de Sanctis D; Payne RJ; Pereira PJB
Cell Chem Biol; 2021 Jan; 28(1):26-33.e8. PubMed ID: 33096052
[TBL] [Abstract][Full Text] [Related]
7. Conformationally restricted analogs of the direct thrombin inhibitor FM 19.
Girnys EA; Porter VR; Mosberg HI
Bioorg Med Chem; 2011 Dec; 19(24):7425-34. PubMed ID: 22055408
[TBL] [Abstract][Full Text] [Related]
8. Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis.
Pavone V; De Simone G; Nastri F; Galdiero S; Staiano N; Lombardi A; Pedone C
Biol Chem; 1998; 379(8-9):987-1006. PubMed ID: 9792431
[TBL] [Abstract][Full Text] [Related]
9. The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element.
Wiley MR; Weir LC; Briggs SL; Chirgadze NY; Clawson D; Gifford-Moore DS; Schacht AL; Smith GF; Vasudevan V; Zornes LL; Klimkowski VJ
Bioorg Med Chem Lett; 1999 Sep; 9(18):2767-72. PubMed ID: 10509932
[TBL] [Abstract][Full Text] [Related]
10. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.
Simpson LS; Zhu JZ; Widlanski TS; Stone MJ
Chem Biol; 2009 Feb; 16(2):153-61. PubMed ID: 19246006
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine sulfation modulates activity of tick-derived thrombin inhibitors.
Thompson RE; Liu X; Ripoll-Rozada J; Alonso-García N; Parker BL; Pereira PJB; Payne RJ
Nat Chem; 2017 Sep; 9(9):909-917. PubMed ID: 28837178
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
Li M; Lin Z; Johnson ME
Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
[TBL] [Abstract][Full Text] [Related]
14. pH-dependent binding constants for the inhibition of thrombin by transition state analogs.
Philipp M; Niua LH; DeSoyza T; Claeson G; Metternich R
Adv Exp Med Biol; 1993; 340():67-77. PubMed ID: 8154344
[No Abstract] [Full Text] [Related]
15. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
[TBL] [Abstract][Full Text] [Related]
16. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y
Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930
[TBL] [Abstract][Full Text] [Related]
17. Mechanism and inhibition kinetics of peptide P13 as thrombin inhibitor.
Chen F; Huang G
Int J Biol Macromol; 2020 May; 150():1046-1052. PubMed ID: 31743711
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.
Wang S; Dai P; Xu Y; Chen Q; Zhu Q; Gong G
Arch Pharm (Weinheim); 2015 Aug; 348(8):595-605. PubMed ID: 26120827
[TBL] [Abstract][Full Text] [Related]
19. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
20. Effect of O-glycosylation and tyrosine sulfation of leech-derived peptides on binding and inhibitory activity against thrombin.
Hsieh YS; Taleski D; Wilkinson BL; Wijeyewickrema LC; Adams TE; Pike RN; Payne RJ
Chem Commun (Camb); 2012 Feb; 48(10):1547-9. PubMed ID: 22109100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
